Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-12-21
pubmed:abstractText
Reactive oxygen species (ROS) have been suggested to play an important role in physiopathology of schizophrenia. The major intracellular antioxidant enzymes, copper-zinc superoxide dismutase in the cytoplasm and manganese superoxide dismutase (Mn-SOD) in the mitochondria, rapidly and specifically reduce superoxide radicals to hydrogen peroxide. Polymorphisms in the genes encoding antioxidant enzymes should therefore result in predisposition to schizophrenia. The present study was performed to assess whether there is a genetic association between a functional polymorphism (Ala-9Val) in the human Mn-SOD gene in schizophrenic patients (n=153) and healthy controls (n=196) using a PCR/RFLP method. Significant differences in the genotypic distribution between schizophrenics and controls were observed. Genotypic distribution with 14 (9.2%) Ala/Ala, 106 (69.3%) Ala/Val and 33 (21.6%) Val/Val subjects in schizophrenia was different from those of controls with 46 (23.5%), 83 (42.3%) and 67 (34.2%), respectively (p<0.0001). When the patients with schizophrenia were divided into the subgroups as disorganized, paranoid and residual, there was a significant difference in genotypic distribution among the subgroups (chi2=11.35, df=4, p=0.023). This association between -9Ala Mn-SOD allele and schizophrenia suggests that -9Ala variant may have a contribution in the physiopathogenesis of schizophrenia. Further investigations are warranted in larger populations with other susceptible genes that might be associated with schizophrenia.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0278-5846
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
123-31
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15610954-Adult, pubmed-meshheading:15610954-Alleles, pubmed-meshheading:15610954-Amino Acid Substitution, pubmed-meshheading:15610954-Antipsychotic Agents, pubmed-meshheading:15610954-Brain, pubmed-meshheading:15610954-Dyskinesia, Drug-Induced, pubmed-meshheading:15610954-Female, pubmed-meshheading:15610954-Gene Frequency, pubmed-meshheading:15610954-Genotype, pubmed-meshheading:15610954-Humans, pubmed-meshheading:15610954-Male, pubmed-meshheading:15610954-Middle Aged, pubmed-meshheading:15610954-Oxidative Stress, pubmed-meshheading:15610954-Polymorphism, Genetic, pubmed-meshheading:15610954-Reactive Oxygen Species, pubmed-meshheading:15610954-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:15610954-Schizophrenia, pubmed-meshheading:15610954-Superoxide Dismutase
pubmed:year
2005
pubmed:articleTitle
Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia.
pubmed:affiliation
Department of Medical Biology and Genetics, Firat University Medical School, Elazig, Turkey. oakyol@hacettepe.edu.tr
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't